{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T13:22:09Z","timestamp":1794057729540,"version":"4.8.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","funder":[{"name":"Foundation for Anesthesia Education and Research","award":["MRTG-02-15-2022-Ansari"],"award-info":[{"award-number":["MRTG-02-15-2022-Ansari"]}],"id":[{"id":"https:\/\/ror.org\/04d16a047","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Society for Obstetric Anesthesia and Perinatology","award":["2020"],"award-info":[{"award-number":["2020"]}],"id":[{"id":"https:\/\/ror.org\/04kcy6a06","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate whether prophylactic administration of 1 g of intravenous calcium chloride after cord clamping reduces blood loss from uterine atony during intrapartum cesarean delivery.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This single-center, block-randomized, placebo-controlled, double-blind superiority trial compared the effects of 1 g intravenous calcium chloride with those of saline placebo control on blood loss at cesarean delivery. Parturients at 34 or more weeks of gestation requiring intrapartum cesarean delivery after oxytocin exposure in labor were enrolled. Calcium or saline placebo was infused over 10 minutes beginning 1\u00a0minute after umbilical cord clamping in addition to standard care with oxytocin. The primary outcome was quantitative blood loss, analyzed by inverse Gaussian regression. Planned subgroup analysis excluded nonatonic bleeding, such as hysterotomy extension, arterial bleeding, and occult placenta accreta. We planned to enroll 120 patients to show a 200-mL reduction in quantitative blood loss in planned subgroup analysis, assuming up to 40% incidence of nonatonic bleeding (80% power, \u03b1&lt;0.05).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>From April 2022 through March 2023, 828 laboring parturients provided consent and 120 participants were enrolled. Median blood loss was 840 mL in patients allocated to calcium chloride (n=60) and 1,051 mL in patients allocated to placebo (n=60), which was not statistically different (mean reduction 211 mL, 95% CI \u221233 to 410). In the planned subgroup analysis (n=39 calcium and n=40 placebo), excluding cases of surgeon-documented nonatonic bleeding, calcium reduced quantitative blood loss by 356 mL (95% CI 159\u2013515). Rates of reported side effects were similar between the two groups (38% calcium vs 42% placebo).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Prophylactic intravenous calcium chloride administered during intrapartum cesarean delivery after umbilical cord clamping did not significantly reduce blood loss in the primary analysis. However, in the planned subgroup analysis, calcium infusion significantly reduced blood loss by approximately 350 mL. These data suggest that this inexpensive and shelf-stable medication warrants future study as a novel treatment strategy to decrease postpartum hemorrhage, the leading global cause of maternal morbidity and mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT 05027048.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000005441","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T17:22:23Z","timestamp":1698945743000},"page":"104-112","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":19,"title":["Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Delivery"],"prefix":"10.1097","volume":"143","author":[{"given":"Jessica R.","family":"Ansari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alla","family":"Yarmosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermina","family":"Michel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deirdre","family":"Lyell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haley","family":"Hedlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Cornfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian T.","family":"Bateman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"R1-20260916","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"R3-20260916","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1056\/NEJMra1513247","article-title":"Postpartum hemorrhage","volume":"384","author":"Bienstock","year":"2021","journal-title":"N Engl J Med"},{"key":"R4-20260916","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(10)60750-7","article-title":"Maternal mortality: one death every 7 min","volume":"375","author":"Potts","year":"2010","journal-title":"Lancet (London, England)"},{"key":"R5-20260916","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1213\/ANE.0b013e3181d74898","article-title":"The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries","volume":"110","author":"Bateman","year":"2010","journal-title":"Anesth Analg"},{"key":"R6-20260916","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.ajog.2005.07.077","article-title":"The MFMU Cesarean Registry: uterine atony after primary cesarean delivery","volume":"193","author":"Rouse","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R7-20260916","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1186\/s12884-021-03818-1","article-title":"Prevalence and risk factors of severe postpartum hemorrhage: a retrospective cohort study","volume":"21","author":"Liu","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"R8-20260916","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0140-6736(10)60348-0","article-title":"Misoprostol as an adjunct to standard uterotonics for treatment of post-partum haemorrhage: a multicentre, double-blind randomised trial","volume":"375","author":"Widmer","year":"2010","journal-title":"Lancet (London, England)"},{"key":"R9-20260916","article-title":"Uterotonic agents for first-line treatment of postpartum haemorrhage: a network meta-analysis","author":"Parry Smith","year":"2020","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"R10-20260916","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/AOG.0000000000004857","article-title":"Prophylactic methylergonovine and oxytocin compared with oxytocin alone in patients undergoing intrapartum cesarean birth: a randomized controlled trial","volume":"140","author":"Masse","year":"2022","journal-title":"Obstet Gynecol"},{"key":"R11-20260916","doi-asserted-by":"crossref","first-page":"103207","DOI":"10.1016\/j.ijoa.2021.103207","article-title":"Refractory uterine atony: still a problem after all these years","volume":"48","author":"Balki","year":"2021","journal-title":"Int J Obstet Anesth"},{"key":"R13-20260916","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1095\/biolreprod40.5.942","article-title":"Effects of external calcium, magnesium, and temperature on spontaneous contractions of pregnant human myometrium","volume":"40","author":"Kawarabayashi","year":"1989","journal-title":"Biol Reprod"},{"key":"R14-20260916","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1213\/ANE.0000000000001264","article-title":"The effect of extracellular calcium on oxytocin-induced contractility in naive and oxytocin-pretreated human myometrium in vitro","volume":"122","author":"Talati","year":"2016","journal-title":"Anesth Analg"},{"key":"R15-20260916","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0002-9378(99)70580-6","article-title":"Intracellular calcium stores and agonist-induced contractions in isolated human myometrium","volume":"181","author":"Luckas","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R16-20260916","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ejogrb.2003.11.032","article-title":"Calcium levels during the initiation of labor","volume":"115","author":"Papandreou","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"R17-20260916","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.bja.2020.11.020","article-title":"Association between ionised calcium and severity of postpartum haemorrhage: a retrospective cohort study","volume":"126","author":"Epstein","year":"2021","journal-title":"Br J Anaesth"},{"key":"R18-20260916","doi-asserted-by":"crossref","first-page":"110796","DOI":"10.1016\/j.jclinane.2022.110796","article-title":"Calcium chloride for the prevention of uterine atony during cesarean delivery: a pilot randomized controlled trial and pharmacokinetic study","volume":"80","author":"Ansari","year":"2022","journal-title":"J Clin Anesth"},{"key":"R19-20260916","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/AOG.0000000000004288","article-title":"Prophylactic administration of uterotonics to prevent postpartum hemorrhage in women undergoing cesarean delivery for arrest of labor: a randomized controlled trial","volume":"137","author":"Balki","year":"2021","journal-title":"Obstet Gynecol"},{"key":"R21-20260916","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.1097\/AOG.0000000000003564","article-title":"Quantitative blood loss in obstetric hemorrhage. ACOG Committee Opinion No. 794. American College of Obstetricians and Gynecologists","volume":"134","year":"2019","journal-title":"Obstet Gynecol"},{"key":"R22-20260916","doi-asserted-by":"crossref","first-page":"103256","DOI":"10.1016\/j.ijoa.2022.103256","article-title":"Quantitative blood loss after vaginal delivery: a retrospective analysis of 104 079 measurements at 41 institutions","volume":"51","author":"Ansari","year":"2022","journal-title":"Int J Obstet Anesth"},{"key":"R23-20260916","doi-asserted-by":"crossref","first-page":"100342","DOI":"10.1016\/j.ajogmf.2021.100342","article-title":"The interrater reliability and agreement of a 0 to 10 uterine tone score in cesarean delivery","volume":"3","author":"Cole","year":"2021","journal-title":"Am J Obstet Gynecol MFM"},{"key":"R24-20260916","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1213\/ANE.0b013e3182691e62","article-title":"The association of maternal race and ethnicity and the risk of postpartum hemorrhage","volume":"115","author":"Bryant","year":"2012","journal-title":"Anesth Analg"},{"key":"R25-20260916","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/S1047-2797(03)00128-5","article-title":"Racial disparity in pregnancy-related mortality following a live birth outcome","volume":"14","author":"Harper","year":"2004","journal-title":"Ann Epidemiol"},{"key":"R26-20260916","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/S0002-9378(99)70573-9","article-title":"Oxytocin-stimulated capacitative calcium entry in human myometrial cells","volume":"181","author":"Monga","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R28-20260916","doi-asserted-by":"crossref","first-page":"e12656","DOI":"10.1002\/rth2.12656","article-title":"Disparities in obstetric hemorrhage outcomes","volume":"6","author":"James","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"R29-20260916","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa2028788","article-title":"Tranexamic acid for the prevention of blood loss after cesarean delivery","volume":"384","author":"Sentilhes","year":"2021","journal-title":"N Engl J Med"},{"key":"R30-20260916","doi-asserted-by":"crossref","first-page":"123.e1","DOI":"10.1016\/j.ajog.2020.01.026","article-title":"Reduction in racial disparities in severe maternal morbidity from hemorrhage in a large-scale quality improvement collaborative","volume":"223","author":"Main","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"R31-20260916","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/GRF.0000000000000349","article-title":"Reducing disparities in severe maternal morbidity and mortality","volume":"61","author":"Howell","year":"2018","journal-title":"Clin Obstet Gynecol"},{"key":"R32-20260916","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.jaci.2014.11.022","article-title":"Neighborhood poverty, urban residence, race\/ethnicity, and asthma: Rethinking the inner-city asthma epidemic","volume":"135","author":"Keet","year":"2015","journal-title":"J Allergy Clin Immunol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005441","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T11:01:49Z","timestamp":1789556509000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/AOG.0000000000005441"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005441","relation":{},"ISSN":["0029-7844","1873-233X"],"issn-type":[{"value":"0029-7844","type":"print"},{"value":"1873-233X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"2023-08-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}